Skip to content
Screener

Shares (Diluted) at other companies

Abbott logo
AbbottABT
1.7B-0.4%
Bio-Rad Laboratories logo
Bio-Rad LaboratoriesBIO
27M-3.6%
Danaher logo
DanaherDHR
707.6M-1.6%
OraSure Technologies logo
OraSure TechnologiesOSUR
70.2M-5.9%
Revvity logo
RevvityRVTY
111.6M-5.0%
Opko Health logo
Opko HealthOPK
755.3M-4.2%

Other financials

Income statement

See full
Revenue$630.9M+2.8%
Gross profit$272.9M-0.7%
Operating income-$21.8M+87.9%
Net income-$92.9M+63.6%
EPS (diluted)-$1.36+63.9%

Balance sheet

See full
Cash & equivalents$123.4M-18.7%
Total debt$3.4B+3.0%
Total equity$1.8B-36.4%
Total assets$5.7B-10.4%

Cash flow

See full
Operating cash flow-$110.6M
CapEx$25.5M-32.0%
Free cash flow-$136.1M-61.4%

Valuation

See full
Market cap$942.91M-41.3%
Enterprise value$4.25B-11.2%
P/S0.4×-0.2×

Profitability

See full
Gross margin44.6%-2.7pp
Operating margin-30.8%-49.9pp
Net margin-39.2%-168pp
FCF margin13.8%

Returns & leverage

See full
Return on equity-45.9%-94.9pp
Debt / equity1.9×+0.7×
Current ratio1.4×+0.3×

Where this comes from

Reported directly by QuidelOrtho Corporation in its filing.

Tagged under the XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding.

The source filing: QuidelOrtho Corporation’s 10-Q, filed August 7, 2026.

Filed
Aug 6, 2026, 8:00 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q3 2026
Accession
0001906324-26-000033
Line itemThree Months Ended / June 28, 2026Three Months Ended / June 29, 2025Six Months Ended / June 28, 2026Six Months Ended / June 29, 2025
Other expense, net4.78.41.39.8
Loss before income taxes(81.2)(229.6)(160.7)(238.4)
Provision for income taxes11.725.824.029.7
Net loss$(92.9)$(255.4)$(184.7)$(268.1)
Basic loss per share$(1.36)$(3.77)$(2.71)$(3.97)
Diluted loss per share$(1.36)$(3.77)$(2.71)$(3.97)
Weighted-average shares outstanding - basic68.367.768.267.6
Weighted-average shares outstanding - diluted68.367.768.267.6

Item 1. Financial Statements (unaudited)

FAQ

What is QuidelOrtho Corporation's shares (diluted)?
QuidelOrtho Corporation (QDEL) reported shares (diluted) of 68.3M in Q2 2026.
How has QuidelOrtho Corporation's shares (diluted) changed year-over-year?
QuidelOrtho Corporation's shares (diluted) increased by 0.9% year-over-year, from 67.7M to 68.3M.
What is the long-term trend for QuidelOrtho Corporation's shares (diluted)?
Over 3 years (2022 to 2025), QuidelOrtho Corporation's shares (diluted) has grown at a 7.2% compound annual growth rate (CAGR), from 220.2M to 271M.
What does shares (diluted) mean?
The weighted-average shares outstanding plus all potentially dilutive shares from stock options, RSUs, convertible securities, and warrants, using the treasury stock method.

Ask your AI about QuidelOrtho Corporation's shares (diluted).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude